Text this: 3O LONG-TERM MAINTENANCE THERAPY WITH THE TLR-9 AGONIST MGN1703 IN A SUBGROUP OF METASTATIC COLORECTAL CANCER PATIENTS FROM THE IMPACT STUDY.